We are live on ! Find out more
IDYA icon

IDEAYA Biosciences
IDYA

89 hedge funds and large institutions have $558M invested in IDEAYA Biosciences in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more capital invested

Capital invested by funds: $284M → $558M (+$275M)

73% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 11

39% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 23

22% more call options, than puts

Call options by funds: $524K | Put options by funds: $428K

9% more funds holding

Funds holding: 82 → 89 (+7)

2.14% more ownership

Funds ownership: 71.55% → 73.69% (+2.1%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
89
Holders Change
+7
Holders Change %
+8.54%
% of All Funds
1.56%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
32
Reduced
23
Closed
11
Calls
$524K
Puts
$428K
Net Calls
+$96K
Net Calls Change
+$251K

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$28.4M
2
RI
RTW Investments
New York
+$12M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$9.81M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$8.29M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$7.87M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$11.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.36M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.52M
4
Two Sigma Investments
Two Sigma Investments
New York
-$1.09M
5
JP Morgan Chase
JP Morgan Chase
New York
-$866K
Name Holding Trade Value Shares
Change 		Change in
Stake
EGI
26
EAM Global Investors
California
$2.17M +$1.78M +92,309 New
N
27
Nuveen
North Carolina
$1.85M -$73.4K -3,800 -5%
Massachusetts Financial Services
28
Massachusetts Financial Services
Massachusetts
$1.61M -$156K -8,105 -11%
EI
29
EAM Investors
California
$1.54M +$1.27M +65,571 New
PVI
30
Pura Vida Investments
New York
$1.43M +$1.17M +60,744 New
Renaissance Technologies
31
Renaissance Technologies
New York
$1.43M -$1.52M -78,700 -56%
JAMONY
32
Jacob Asset Management of New York
California
$1.27M +$347K +18,000 +50%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.14M +$5.31K +275 +0.6%
SCM
34
Sio Capital Management
New York
$1.14M – – –
Charles Schwab
35
Charles Schwab
California
$1.03M +$89.1K +4,614 +12%
TD Asset Management
36
TD Asset Management
Ontario, Canada
$891K +$278K +14,405 +61%
Ensign Peak Advisors
37
Ensign Peak Advisors
Utah
$868K – – –
Goldman Sachs
38
Goldman Sachs
New York
$809K +$97.2K +5,036 +17%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$761K -$59.7K -3,090 -9%
JP Morgan Chase
40
JP Morgan Chase
New York
$749K -$866K -44,840 -58%
AQR Capital Management
41
AQR Capital Management
Connecticut
$730K -$152K -7,893 -20%
ABG
42
Ally Bridge Group
New York
$705K +$579K +30,000 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$626K +$48.8K +2,527 +10%
Squarepoint
44
Squarepoint
New York
$558K -$138K -7,156 -23%
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$519K – – –
Wells Fargo
46
Wells Fargo
California
$472K -$326K -16,903 -46%
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
$453K -$191K -9,904 -34%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$437K +$21K +1,089 +6%
Ameriprise
49
Ameriprise
Minnesota
$358K – – –
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$348K +$73.4K +3,800 +35%
1
2
3 4

IDYA Hedge Fund Activity: Q1 2021 in Review

89 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q1 2021, worth a combined $558M — up 97% from $284M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new IDYA positions and 11 closed out — a net gain of 8 holders — while 32 added to existing stakes and 23 trimmed.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $28.4M. The largest seller was BVF Inc, cutting an estimated $11.9M.

  • 89 institutional investors held IDEAYA Biosciences (IDYA) as of Q1 2021, up from 82 in Q4 2020.
  • Funds reported $558M of IDEAYA Biosciences stock for Q1 2021, up 97% quarter-over-quarter.
  • 19 funds opened new IDEAYA Biosciences positions in Q1 2021 and 11 closed out, a net change of +8 holders.
  • The largest IDEAYA Biosciences buyer in Q1 2021 was Avidity Partners Management, an estimated $28.4M added.
  • The largest IDEAYA Biosciences seller in Q1 2021 was BVF Inc, an estimated $11.9M sold.

Based on aggregated 13F filings for Q1 2021.